GlassScriptPhysician profile
Anitha Police
NPI 1821127903
$6,721.76
in general payments reported to CMS, 2019-2025
42 companies · $1,016 in 2025
The $1,016 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $793 · 2020: $837 · 2021: $1,057 · 2022: $710 · 2023: $1,206 · 2024: $1,103 · 2025: $1,016.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,325.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,424.03 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $758.70 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $419.29 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Abbott Laboratories | $416.61 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Abbvie INC. | $379.46 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $371.87 | 2019-2025 | Jardiance |
| Amgen INC. | $355.32 | 2019-2025 | Repatha, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $327.83 | 2019-2025 | Airsupra, Breztri |
| Biohaven Pharmaceuticals, INC. | $236.52 | 2021 | |
| Astellas Pharma US INC | $224.11 | 2020-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $222.10 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $189.91 | 2019-2025 | Steglatro, Capvaxive |
| Eisai INC. | $121.66 | 2020-2022 | |
| Vivus LLC | $97.87 | 2019-2023 | Qsymia |
| Biohaven Pharmaceutical Holding Company LTD. | $97.40 | 2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anitha Police listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.